位置:首页 > 蛋白库 > GRHL2_MOUSE
GRHL2_MOUSE
ID   GRHL2_MOUSE             Reviewed;         625 AA.
AC   Q8K5C0; Q80UZ5;
DT   21-MAR-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   03-AUG-2022, entry version 141.
DE   RecName: Full=Grainyhead-like protein 2 homolog;
DE   AltName: Full=Brother of mammalian grainyhead;
DE   AltName: Full=Transcription factor CP2-like 3;
GN   Name=Grhl2; Synonyms=Bom, Tcfcp2l3;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND DEVELOPMENTAL STAGE.
RC   TISSUE=Teratocarcinoma;
RX   PubMed=12175488; DOI=10.1016/s0925-4773(02)00046-1;
RA   Wilanowski T., Tuckfield A., Cerruti L., O'Connell S., Saint R., Parekh V.,
RA   Tao J., Cunningham J.M., Jane S.M.;
RT   "A highly conserved novel family of mammalian developmental transcription
RT   factors related to Drosophila grainyhead.";
RL   Mech. Dev. 114:37-50(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Czech II; TISSUE=Mammary tumor, and Olfactory epithelium;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=12393799; DOI=10.1093/hmg/11.23.2877;
RA   Peters L.M., Anderson D.W., Griffith A.J., Grundfast K.M.,
RA   San Agustin T.B., Madeo A.C., Friedman T.B., Morell R.J.;
RT   "Mutation of a transcription factor, TFCP2L3, causes progressive autosomal
RT   dominant hearing loss, DFNA28.";
RL   Hum. Mol. Genet. 11:2877-2885(2002).
RN   [4]
RP   FUNCTION, DISRUPTION PHENOTYPE, DEVELOPMENTAL STAGE, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=20978075; DOI=10.1242/dev.055483;
RA   Werth M., Walentin K., Aue A., Schonheit J., Wuebken A., Pode-Shakked N.,
RA   Vilianovitch L., Erdmann B., Dekel B., Bader M., Barasch J., Rosenbauer F.,
RA   Luft F.C., Schmidt-Ott K.M.;
RT   "The transcription factor grainyhead-like 2 regulates the molecular
RT   composition of the epithelial apical junctional complex.";
RL   Development 137:3835-3845(2010).
RN   [5]
RP   FUNCTION, DISRUPTION PHENOTYPE, AND DEVELOPMENTAL STAGE.
RX   PubMed=20654612; DOI=10.1016/j.ydbio.2010.07.017;
RA   Rifat Y., Parekh V., Wilanowski T., Hislop N.R., Auden A., Ting S.B.,
RA   Cunningham J.M., Jane S.M.;
RT   "Regional neural tube closure defined by the Grainy head-like transcription
RT   factors.";
RL   Dev. Biol. 345:237-245(2010).
RN   [6]
RP   FUNCTION.
RX   PubMed=21081122; DOI=10.1016/j.ydbio.2010.11.011;
RA   Boglev Y., Wilanowski T., Caddy J., Parekh V., Auden A., Darido C.,
RA   Hislop N.R., Cangkrama M., Ting S.B., Jane S.M.;
RT   "The unique and cooperative roles of the Grainy head-like transcription
RT   factors in epidermal development reflect unexpected target gene
RT   specificity.";
RL   Dev. Biol. 349:512-522(2011).
RN   [7]
RP   FUNCTION, AND DEVELOPMENTAL STAGE.
RX   PubMed=22955271; DOI=10.1074/jbc.m112.408401;
RA   Varma S., Cao Y., Tagne J.B., Lakshminarayanan M., Li J., Friedman T.B.,
RA   Morell R.J., Warburton D., Kotton D.N., Ramirez M.I.;
RT   "The transcription factors Grainyhead-like 2 and NK2-homeobox 1 form a
RT   regulatory loop that coordinates lung epithelial cell morphogenesis and
RT   differentiation.";
RL   J. Biol. Chem. 287:37282-37295(2012).
RN   [8]
RP   FUNCTION, DEVELOPMENTAL STAGE, AND SUBCELLULAR LOCATION.
RX   PubMed=22696678; DOI=10.1091/mbc.e12-02-0097;
RA   Senga K., Mostov K.E., Mitaka T., Miyajima A., Tanimizu N.;
RT   "Grainyhead-like 2 regulates epithelial morphogenesis by establishing
RT   functional tight junctions through the organization of a molecular network
RT   among claudin3, claudin4, and Rab25.";
RL   Mol. Biol. Cell 23:2845-2855(2012).
CC   -!- FUNCTION: Transcription factor playing an important role in primary
CC       neurulation and in epithelial development. Binds directly to the
CC       consensus DNA sequence 5'-AACCGGTT-3' acting as an activator and
CC       repressor on distinct target genes (PubMed:22696678). During
CC       embryogenesis, plays unique and cooperative roles with GRHL3 in
CC       establishing distinct zones of primary neurulation. Essential for
CC       closure 3 (rostral end of the forebrain), functions cooperatively with
CC       GRHL3 in closure 2 (forebrain/midbrain boundary) and posterior
CC       neuropore closure (PubMed:20654612). Regulates epithelial morphogenesis
CC       acting as a target gene-associated transcriptional activator of apical
CC       junctional complex components. Up-regulates of CLDN3 and CLDN4, as well
CC       as of RAB25, which increases the CLDN4 protein and its localization at
CC       tight junctions (PubMed:22696678). Comprises an essential component of
CC       the transcriptional machinery that establishes appropriate expression
CC       levels of CLDN4 and CDH1 in different types of epithelia
CC       (PubMed:20978075). Exhibits functional redundancy with GRHL3 in
CC       epidermal morphogenetic events such as eyelid fusion and epidermal
CC       wound repair (PubMed:21081122). In lung, forms a regulatory loop with
CC       NKX2-1 that coordinates lung epithelial cell morphogenesis and
CC       differentiation (PubMed:22955271). In keratinocytes, plays a role in
CC       telomerase activation during cellular proliferation, regulates TERT
CC       expression by binding to TERT promoter region and inhibiting DNA
CC       methylation at the 5'-CpG island, possibly by interfering with DNMT1
CC       enzyme activity. In addition, impairs keratinocyte differentiation and
CC       epidermal function by inhibiting the expression of genes clustered at
CC       the epidermal differentiation complex (EDC) as well as GRHL1 and GRHL3
CC       through epigenetic mechanisms (By similarity).
CC       {ECO:0000250|UniProtKB:Q6ISB3, ECO:0000269|PubMed:20654612,
CC       ECO:0000269|PubMed:20978075, ECO:0000269|PubMed:21081122,
CC       ECO:0000269|PubMed:22696678, ECO:0000269|PubMed:22955271}.
CC   -!- SUBUNIT: Homodimer, also forms heterodimers with GRHL1 or GRHL3.
CC       {ECO:0000250|UniProtKB:Q6ISB3}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20978075,
CC       ECO:0000269|PubMed:22696678}. Membrane {ECO:0000250|UniProtKB:Q6ISB3}.
CC       Note=detected at cell-cell contact areas.
CC       {ECO:0000250|UniProtKB:Q6ISB3}.
CC   -!- DEVELOPMENTAL STAGE: At 14.5 dpc expressed in lung, esophagus, skin and
CC       kidney. At 9.5 dpc expressed in foregut and surface ectoderm but not in
CC       the neural tube. At 9.5 dpc and 15.5 dpc, detected in the lung
CC       epithelium and in branchiolar and alveolar epithelial cells at 18.5 dpc
CC       and adult. Expressed in otocyst at 11.5 dpc, prominent in epithelial
CC       derivatives of the otic placode in the vestibule and cochlear duct at
CC       18.5 dpc. At postnatal day 5, epithelial cells of the cochlear duct,
CC       which surround the endolymph-containing scala media, continued to
CC       express low levels, while little or no expression was seen in the
CC       mesenchyme-derived cells lining the scala tympani and scala vestibuli.
CC       Detected in cholangiocytes in postnatal day 1 and postnatal day 8
CC       livers. {ECO:0000269|PubMed:12175488, ECO:0000269|PubMed:12393799,
CC       ECO:0000269|PubMed:20654612, ECO:0000269|PubMed:20978075,
CC       ECO:0000269|PubMed:22696678, ECO:0000269|PubMed:22955271}.
CC   -!- DISRUPTION PHENOTYPE: Mutant embryos show an epithelial and anterior
CC       and posterior neural tube defects leading to death at around 11.5 dpc
CC       (PubMed:20654612, PubMed:20978075). They exhibit a fully penetrant
CC       split-face malformation, associated with cranioschisis. Closure of the
CC       remainder of the neural tube ocrurred normally with the exception of
CC       the posterior neuropore. The dorso-lateral hinge points fail to form
CC       and closure do not proceed beyond this point (PubMed:20654612).
CC       {ECO:0000269|PubMed:20654612, ECO:0000269|PubMed:20978075}.
CC   -!- MISCELLANEOUS: GRHL genes (GRHL1, GRHL2 and GRHL3) show a paradoxal
CC       lack of redundancy despite their extensive sequence identity in the
CC       DNA-binding and protein dimerization domains and the fact that the core
CC       consensus DNA binding sites are identical. They have related but
CC       remarkably different functions during embryogenesis because of their
CC       differential spatiotemporal expression patterns during development.
CC       {ECO:0000305|PubMed:21081122}.
CC   -!- SIMILARITY: Belongs to the grh/CP2 family. Grainyhead subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF411213; AAM22619.1; -; mRNA.
DR   EMBL; BC042575; AAH42575.1; -; mRNA.
DR   EMBL; BC055035; AAH55035.1; -; mRNA.
DR   CCDS; CCDS27434.1; -.
DR   RefSeq; NP_080772.2; NM_026496.4.
DR   AlphaFoldDB; Q8K5C0; -.
DR   SMR; Q8K5C0; -.
DR   BioGRID; 232985; 5.
DR   IntAct; Q8K5C0; 3.
DR   MINT; Q8K5C0; -.
DR   STRING; 10090.ENSMUSP00000022895; -.
DR   iPTMnet; Q8K5C0; -.
DR   PhosphoSitePlus; Q8K5C0; -.
DR   MaxQB; Q8K5C0; -.
DR   PaxDb; Q8K5C0; -.
DR   PeptideAtlas; Q8K5C0; -.
DR   PRIDE; Q8K5C0; -.
DR   ProteomicsDB; 271297; -.
DR   Antibodypedia; 1306; 162 antibodies from 21 providers.
DR   DNASU; 252973; -.
DR   Ensembl; ENSMUST00000022895; ENSMUSP00000022895; ENSMUSG00000022286.
DR   GeneID; 252973; -.
DR   KEGG; mmu:252973; -.
DR   UCSC; uc007vne.2; mouse.
DR   CTD; 79977; -.
DR   MGI; MGI:2182543; Grhl2.
DR   VEuPathDB; HostDB:ENSMUSG00000022286; -.
DR   eggNOG; KOG4091; Eukaryota.
DR   GeneTree; ENSGT00940000155788; -.
DR   HOGENOM; CLU_021156_1_1_1; -.
DR   InParanoid; Q8K5C0; -.
DR   OMA; XGTFQYT; -.
DR   OrthoDB; 286319at2759; -.
DR   PhylomeDB; Q8K5C0; -.
DR   TreeFam; TF314132; -.
DR   BioGRID-ORCS; 252973; 1 hit in 73 CRISPR screens.
DR   ChiTaRS; Grhl2; mouse.
DR   PRO; PR:Q8K5C0; -.
DR   Proteomes; UP000000589; Chromosome 15.
DR   RNAct; Q8K5C0; protein.
DR   Bgee; ENSMUSG00000022286; Expressed in lacrimal gland and 203 other tissues.
DR   ExpressionAtlas; Q8K5C0; baseline and differential.
DR   Genevisible; Q8K5C0; MM.
DR   GO; GO:0005911; C:cell-cell junction; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IDA:MGI.
DR   GO; GO:0031490; F:chromatin DNA binding; ISS:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IDA:MGI.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISS:UniProtKB.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IDA:UniProtKB.
DR   GO; GO:0001161; F:intronic transcription regulatory region sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0061713; P:anterior neural tube closure; IMP:MGI.
DR   GO; GO:0070830; P:bicellular tight junction assembly; ISS:UniProtKB.
DR   GO; GO:0007420; P:brain development; IMP:MGI.
DR   GO; GO:0043010; P:camera-type eye development; IMP:MGI.
DR   GO; GO:0003208; P:cardiac ventricle morphogenesis; IMP:MGI.
DR   GO; GO:0007155; P:cell adhesion; ISS:UniProtKB.
DR   GO; GO:0034329; P:cell junction assembly; ISS:UniProtKB.
DR   GO; GO:0008283; P:cell population proliferation; ISO:MGI.
DR   GO; GO:0048701; P:embryonic cranial skeleton morphogenesis; IMP:MGI.
DR   GO; GO:0042733; P:embryonic digit morphogenesis; IMP:MGI.
DR   GO; GO:0048568; P:embryonic organ development; IMP:MGI.
DR   GO; GO:0008544; P:epidermis development; IMP:UniProtKB.
DR   GO; GO:0003382; P:epithelial cell morphogenesis; IMP:UniProtKB.
DR   GO; GO:0060672; P:epithelial cell morphogenesis involved in placental branching; IMP:MGI.
DR   GO; GO:0090132; P:epithelium migration; IMP:UniProtKB.
DR   GO; GO:0060324; P:face development; IMP:MGI.
DR   GO; GO:0001701; P:in utero embryonic development; IMP:MGI.
DR   GO; GO:0060487; P:lung epithelial cell differentiation; IMP:UniProtKB.
DR   GO; GO:0060463; P:lung lobe morphogenesis; IMP:MGI.
DR   GO; GO:0035264; P:multicellular organism growth; IMP:MGI.
DR   GO; GO:0045617; P:negative regulation of keratinocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0001843; P:neural tube closure; IMP:UniProtKB.
DR   GO; GO:0021915; P:neural tube development; IMP:MGI.
DR   GO; GO:0051973; P:positive regulation of telomerase activity; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:CACAO.
DR   GO; GO:0044030; P:regulation of DNA methylation; ISS:UniProtKB.
DR   GO; GO:0010468; P:regulation of gene expression; IMP:MGI.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IDA:MGI.
DR   GO; GO:0030323; P:respiratory tube development; IMP:MGI.
DR   InterPro; IPR007604; CP2.
DR   Pfam; PF04516; CP2; 1.
DR   PROSITE; PS51968; GRH_CP2_DB; 1.
PE   2: Evidence at transcript level;
KW   Activator; DNA-binding; Membrane; Nucleus; Reference proteome;
KW   Transcription; Transcription regulation.
FT   CHAIN           1..625
FT                   /note="Grainyhead-like protein 2 homolog"
FT                   /id="PRO_0000227995"
FT   DOMAIN          244..482
FT                   /note="Grh/CP2 DB"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01313"
FT   REGION          1..93
FT                   /note="Transcription activation"
FT                   /evidence="ECO:0000269|PubMed:20978075"
FT   REGION          198..222
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          428..452
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        198..219
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        438..452
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            423
FT                   /note="Important for activation of transcription"
FT                   /evidence="ECO:0000250|UniProtKB:Q6ISB3"
SQ   SEQUENCE   625 AA;  71195 MW;  879EE7689A5AA4E3 CRC64;
     MSQESDNNKR LVALVPMPSD PPFNTRRAYT SEDEAWKSYL ENPLTAATKA MMSINGDEDS
     AAALGLLYDY YKVPRDKRLL SVSKASDSQE DQDKRNCLGT SEAQINLSGG ENRVQVLKTV
     PVNLCLSQDH MENSKREQYS VSITESSAVI PVSGITVVKA EDFTPVFMAP PVHYPRADSE
     EQRVVIFEQT QYDLPSIASH SSYLKDDQRS TPDSTYSESF KDGASEKFRS TSVGADEYTY
     DQTGSGTFQY TLEATKSLRQ KQGEGPMTYL NKGQFYAITL SETGDNKCFR HPISKVRSVV
     MVVFSEDKNR DEQLKYWKYW HSRQHTAKQR VLDIADYKES FNTIGNIEEI AYNAVSFTWD
     VNEEAKIFIT VNCLSTDFSS QKGVKGLPLM IQIDTYSYNN RSNKPIHRAY CQIKVFCDKG
     AERKIRDEER KQNRKKGKGQ ASQAQCNNSS DGKMAAIPLQ KKSDITYFKT MPDLHSQPVL
     FIPDVHFANL QRTGQVYYNT DDEREGSSVL VKRMFRPMEE EFGPTPSKQI KEENVKRVLL
     YVRKENDDVF DALMLKSPTV KGLMEALSEK YGLPVEKITK LYKKSKKGIL VNMDDNIIEH
     YSNEDTFILN MESMVEGFKI TLMEI
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024